---
title: "FLYNN DANIEL LEE — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0d65579b-c188-595e-be37-e1b7ebb0aa3e
json: https://whiteintel.dev/api/public/dossier/0d65579b-c188-595e-be37-e1b7ebb0aa3e
identifier: sec:0001713712
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# FLYNN DANIEL LEE

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001713712`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0d65579b-c188-595e-be37-e1b7ebb0aa3e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0d65579b-c188-595e-be37-e1b7ebb0aa3e  

## Ownership & control

### Holdings / subsidiaries

- **DECIPHERA PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/f5c2a4c6-e983-5aa5-8c4f-2cd2cceac5f0

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **FLYNN DANIEL LEE**. Human view: https://whiteintel.dev/entity/0d65579b-c188-595e-be37-e1b7ebb0aa3e · Structured JSON: https://whiteintel.dev/api/public/dossier/0d65579b-c188-595e-be37-e1b7ebb0aa3e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._